Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inari Medical, Inc. (NARI)
NASDAQ:NARI
NARI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$36.73 - $79.99
Previous CloseN/A
Volume5.06M
Average Volume (3M)3.57M
Market Cap
$4.68B
Enterprise Value$2.33B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.52
Next Earnings
Mar 04, 2025EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.35
Shares Outstanding58,563,590
10 Day Avg. Volume1,089,736
30 Day Avg. Volume3,566,871
Standard Deviation0.15
R-Squared0.10
Alpha0.00703
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)8.15
Price to Cash Flow (P/CF)431.60
P/FCF Ratio0.00
Enterprise Value/Market Cap0.50
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.36
Enterprise Value/Ebitda-64.39
Forecast
1Y Price Target
$75.80Price Target Upside-5.21% Downside
Rating ConsensusHold
Number of Analyst Covering13
---
Inari Medical News
PremiumCompany Announcements
Inari Medical Merges with Stryker, Delists from Nasdaq
---
Bulls Say, Bears Say
Bulls Say
Acquisition PremiumNARI announced it has entered into an agreement to be acquired by SYK for $80/share, representing a 61% premium to Friday's closing price.
International ExpansionSYK brings a significant increase in financial resources and a global footprint, which is expected to support NARI's expansion outside the United States.
Market LeadershipNARI stands to benefit as the largest player in the VTE space, with MT increasingly supplanting CDT and anticoagulants within intermediate- and high-risk VTE patients.
Bears Say
DOJ InvestigationCertain idiosyncratic risks, such as the ongoing DOJ investigation into NARI's sales practices, contribute to the competitive environment and potential market share erosion.
Limited SynergiesThere is limited potential for commercial or cost synergies due to limited overlap in customer call points between NARI and SYK.
Rating DowngradeIn light of the announced acquisition, the rating on NARI shares is lowered from Buy to Hold.
---
Ownership Overview
11.34% Insiders
26.75% Mutual Funds
27.28% Other Institutional Investors
9.31% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NARI FAQ
What was Inari Medical, Inc.’s price range in the past 12 months?
Inari Medical, Inc. lowest stock price was $36.73 and its highest was $79.99 in the past 12 months.
What is Inari Medical, Inc.’s market cap?
Inari Medical, Inc.’s market cap is $4.68B.
When is Inari Medical, Inc.’s upcoming earnings report date?
Inari Medical, Inc.’s upcoming earnings report date is Mar 04, 2025 which is in 11 days.
How were Inari Medical, Inc.’s earnings last quarter?
Inari Medical, Inc. released its earnings results on Oct 28, 2024. The company reported -$0.084 earnings per share for the quarter, beating the consensus estimate of -$0.116 by $0.032.
Is Inari Medical, Inc. overvalued?
According to Wall Street analysts Inari Medical, Inc.’s price is currently Overvalued.
Does Inari Medical, Inc. pay dividends?
Inari Medical, Inc. does not currently pay dividends.
What is Inari Medical, Inc.’s EPS estimate?
Inari Medical, Inc.’s EPS estimate is -0.05.
How many shares outstanding does Inari Medical, Inc. have?
Inari Medical, Inc. has 58,563,590 shares outstanding.
What happened to Inari Medical, Inc.’s price movement after its last earnings report?
Inari Medical, Inc. reported an EPS of -$0.084 in its last earnings report, beating expectations of -$0.116. Following the earnings report the stock price went up 15.555%.
Which hedge fund is a major shareholder of Inari Medical, Inc.?
Currently, no hedge funds are holding shares in NARI
---
Inari Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$75.80 (-5.21% Downside)
$75.80 (-5.21% Downside)
Blogger Sentiment
Bullish
NARI Sentiment 75%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 2.2%
Last 30 Days ▼ 2.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
―
20 days / 200 days
Momentum
36.84%
12-Months-Change
Fundamentals
Return on Equity
-17.72%
Trailing 12-Months
Asset Growth
27.04%
Trailing 12-Months
Company Description
Inari Medical, Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States.
---
NARI Company Deck
---
NARI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
Inari Medical's Q3 2024 earnings call highlighted strong revenue growth, international expansion, and the upcoming PEERLESS study as significant positive developments. However, the company faced challenges with increased operating expenses and a net loss, suggesting a mixed but cautiously optimistic outlook.Read More>---
NARI Revenue Breakdown
95.19% U.S.
4.81% International
---
NARI Stock 12 Month Forecast
Average Price Target
$75.80
▼(-5.21% Downside)
Technical Analysis
Abbott Laboratories
―
Boston Scientific
―
Intuitive Surgical
―
Johnson & Johnson
―
Penumbra
―
Best Analysts Covering NARI
1 Year
1 Year Success Rate
7/11 ratings generated profit
1 Year Average Return
+24.97%
reiterated a buy rating 2 months ago
Copying Travis Steed's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +24.97% per trade.
---